Domov › Metastatická rakovina › Alabama
Klinické štúdie Metastatická rakovina v štáte Alabama
13 štúdií pre Metastatická rakovina hľadá účastníkov v zariadeniach v štáte Alabama.
Mestá v štáte Alabama
Oficiálny text štúdie (anglicky)
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Clearview Cancer Institute, Huntsville
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07562152Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of Alabama at Birmingham Cancer Center, Birmingham
- University of South Alabama Mitchell Cancer Institute, Mobile
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05564377PRE-ISPY Phase I/II Oncology Platform Program
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05868226Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- The University of Alabama at Birmingham, Birmingham
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06943755A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Daphne
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06103864A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06989437A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Alabama at Birmingham, Birmingham
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213804CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Clinical Study Site, Birmingham
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07335497A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
Prebieha náborFáza 1
36 Months – 22 Years · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT03911388A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Alabama at Birmingham, Birmingham
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT04657068LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Central Alabama Research, Birmingham
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 6. 2026 · NCT06216301SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.